This course will be of interest to all Quality professionals. The material covers the use and application of Basic statistical tools and techniques. The course will introduce basic data collection and sampling methods, control charts, graphical methods, and practical application areas in statistical quality control.
Learn to significantly reduce the recurrence of quality, safety or environmental problems. Upon completion of this workshop, one will be able to understand selected root cause analysis and corrective action terminology; understand and perform or facilitate root cause analysis using a variety of techniques – e.g., Change Analysis, Failure Mode and Effects Analysis, Hazard-Barrier-Effects Analysis, Time-line Analysis, Cause and Effects Analysis. Continue reading Root Cause Analysis Workshop – April 18th→
Brookhaven National Laboratory is a nonprofit research and development institution whose purpose is to advance ideas and knowledge through a multidisciplinary program of basic and applied research. The Laboratory is implementing a Deployed Quality Services model with the goal of improving the Quality Assurance capability in the Environment, Safety & Health Directorate. The Quality Management Office has a full time opportunity for the position of Quality Engineer. Continue reading Quality Engineer needed at Brookhaven National Laboratory→
Congratulations to the current NY/NJ Metropolitan Section Chair. ASQ has announced Austin as ASQ’s 2013 Feigenbaum Medal recipient!
In part the citation reads:
“For the interdisciplinary collaborative application of quality methods, both within and beyond the quality profession’s traditional scope, with an emphasis on career development and nurturing the growth of professions’ future leaders.”
The presentation of the medal will take place on Sunday afternoon, May 5th prior to ASQ’s annual business meeting which will take place as part of ASQ’s World Conference on Quality and Improvement to be held at the Indianapolis Convention Center in Indianapolis IN May 6 – 8, 2013.
“The Feigenbaum Medal is presented to the individual who is 35 years of age or younger, who has displayed outstanding characteristics of leadership, professionalism, and potential in the field of quality and also whose work has been or, will become of distinct benefit to mankind.”
I. Presentation overview—Lynn Tang, PhD, Associate Professor, College of New Jersey
China’s 12th Five Year Plan (2011-2015) offers an important framework for China’s economic and social development. It is also a significant document for China’s partners in the world economy because it presents both opportunities to do business with China and challenges to compete with Chinese companies in the global marketplace. Policy makers should also heed to China’s call for accomplishing the Plan’s goals.
The presentation briefly describes the nature of the Plan and explains the implications of the Plan to US businesses. Emphasis is placed on opportunities in China for companies in the health, technology and environmental sectors over the next 5-10 years.
The presenter will encourage wide audience participation. Several simple questions will be posed to the audience at the beginning of the presentation to engage them in discussion. Participants will benefit from the presentation by learning about the planned direction of the Chinese economy over the next few years, the implications of China’s policies for domestic and international business, and the role that U.S. businesses can play in this new economic environment.
Since 2001, when China entered the World Trade Organization, to today when China has hosted the Summer Olympics in 2008 and the World Expo in 2010, the country has evolved into the global low-cost Manufacturing powerhouse with a sizeable sovereign wealth of about USD $3 trillion. Beginning a new decade, we see a changing Healthcare and Life Sciences landscape in the 21st Century with China developing and becoming a new Global Epicenter for Life Sciences Research and Innovation. The U.S. may still be the world’s superpower, but China and India are rapidly vying for world dominance in Biopharma by adding more research and innovation to their life sciences industry. There is a growing competition among these three nations for biopharma enterprises and their jobs, as they all look to this industry (pharmaceutical and biotech) for future growth.
The presentation will briefly describe the current market landscape in China and summarize the implications of Quality to US health, technology and environment businesses. Emphasis will be placed on new regulations that may have relevance to other industries. The presenter will discuss challenges and opportunities in China for U.S. companies in this decade. Continue reading Economic and Quality Trends in China: Challenges and Opportunities→